Chief Executive Officer – In
After gaining a PhD in pharmacology from the University of Dijon in 1992, Philippe Genne began his scientific career as a project leader at Debiopharm where he oversaw a clinical development program related to multi-drug resistance inhibitors. From 1992 to 1998, he also conducted preclinical development and phase I and phase II clinical trials in conjunction with Inserm. In 1995, he founded Oncodesign Biotechnology in Dijon. From that point, he has earned a reputation as a serial entrepreneur in life sciences.
He is the root to the creation and development of Oncodesign, listed on Euronext Growth from 1995 to 2022 (45 millions € revenues in 2022), and its restructuration in 2 seperate companies Oncodesign Services (ODS) and OPM. Philippe Genne is well known for his activities right across the life sciences value chain. In 2012, he helped set up the French association of life sciences service and innovation companies (AFSSI). Since 2018, he is the Vice-President of the SMEs College at Medicen.